Alkermes (ALKS) Common Equity (2010 - 2026)

Alkermes (ALKS) has 17 years of Common Equity data on file, last reported at $1.8 billion in Q1 2026.

• On a quarterly basis, Common Equity rose 15.87% year-over-year to $1.8 billion in Q1 2026; TTM through Mar 2026 was $1.8 billion, a 15.87% increase from a year earlier, with the FY2025 full-year figure at $1.8 billion, up 24.19% from the prior year.
• Common Equity for Q1 2026 stood at $1.8 billion, down from $1.8 billion in the prior quarter.
• Over the last five years, Common Equity for ALKS reached as high as $1.8 billion in Q4 2025 and fell as low as $1.0 billion in Q1 2023.
• Historically, Common Equity has averaged $1.3 billion across 5 years, with a median of $1.3 billion in 2024.
• Across the five-year window, Common Equity declined 6.49% in 2023 and jumped 34.16% in 2025, its largest moves.
• Year by year, Common Equity stood at $1.0 billion in 2022, then increased by 15.23% to $1.2 billion in 2023, then grew by 21.81% to $1.5 billion in 2024, then gained by 24.19% to $1.8 billion in 2025, then slipped by 3.72% to $1.8 billion in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $1.8 billion in Q1 2026, $1.8 billion in Q4 2025, and $1.7 billion in Q3 2025.